IF 14.3CT甲状腺癌2026-03
Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer.
Zhang T, Cui W, Tang H et al. · Cell Rep Med
结论本研究为晚期分化型甲状腺癌的个性化治疗提供了理论依据和实用工具。这一分型框架有望指导未来的临床实践，优化晚期分化型甲状腺癌患者的治疗方案。
PMID: 41794039DOI ↗